Picture of Kyowa Kirin logo

4151 — Kyowa Kirin News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Garuda Therapeutics Closes $50 Million Series A-1 Financing To Advance Off-The-Shelf Blood Stem Cell Therapies

March 4 (Reuters) - Kyowa Kirin Co Ltd 4151.T:

GARUDA THERAPEUTICS CLOSES $50 MILLION SERIES A-1 FINANCING TO ADVANCE OFF-THE-SHELF BLOOD STEM CELL THERAPIES

GARUDA: INVESTORS INCLUDED ORBIMED, NORTHPOND VENTURES AND CORMORANT ASSET MANAGEMENT, WITH NEW STRATEGIC INVESTMENT FROM KYOWA KIRIN CO., LTD

Source text: ID:nGNX9G7mV9

Further company coverage: 4151.T

 (Reuters.Briefs@thomsonreuters.com)

Recent news on Kyowa Kirin

See all news